ID

42476

Descrição

Study Title: LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients https://leoss.net Study Indication: COVID-19 Date: 19.03.2021 Published with permission by Prof. Dr. med. J.-J. Vehreschild. LEOSS, a multi-center cohort study, has been created to get more in-depth knowledge about the epidemiology and clinical course of patients infected with SARS-CoV-2. Initiated by the ESCMID Emerging Infections Task Force (EITaF) and the German Infectious Disease Society, and supported by all German Centers for Health Research (DZG), LEOSS has developed into an international network of contributors. Via an integrative research approach with anonymous recruitment and collection of routine data in an open science context, LEOSS is building a uniform clinical dataset and providing real-time analyses. For more information feel free to explore https://leoss.net/. Please note that only cases with known outcome are collected! Baseline / diagnosis is defined as the day the sample of the first positive SARS-CoV-2 result was taken. Criteria of the Uncomplicated Phase: Asymptomatic OR Symptoms of upper respiratory tract infection and/or Nausea, emesis, diarrhea and/or Fever Remember: The Uncomplicated Phase ends, if a previously febrile patient has no fever anymore and has completed 14 days of follow-up without entering Complicated or Critical Phase; then move to Recovery Phase. Also, as soon as one of the criteria of the Complicated or Critical Phase are fulfilled, Uncomplicated Phase ends; move over to there. If the patient has died, the phase ends with the death of the patient. If the patient has died, do not report terminal values, e.g. those recorded after switching off life-support or heart rate "0" after death of the patient. Criteria of the Complicated Phase: * Need for oxygen supplementation (In patients with prior oxygen home therapy, clinically meaningful increase in need for oxygenation.) * paO2 at room air < 70 mmHg * SO2 at room air < 90 % * GOT or GPT > 5x ULN * New cardiac arrhythmia * New pericardial effusion >1cm * New heart failure with pulmonary edema, congestive hepatopathy or peripheral edema Remember: The Complicated Phase ends, if none of the criteria for the Complicated Phase is fulfilled anymore AND the patient is free of fever; then move to Recovery Phase. Also, as soon as one of the criteria of the Critical Phase are fulfilled, Complicated Phase ends; move over to Critical Phase. If the patient has died, the phase ends with the death of the patient. If the patient has died, do not report terminal values, e.g. those recorded after switching off life-support or heart rate "0" after death of the patient. Criteria of the Critical Phase: * Need for catecholamines * Life-threatening cardiac arrhythmia * Mechanical ventilation (invasive or non-invasive) * Liver failure with Quick< 50% * qSOFA >= 2 * Renal failure in need of dialysis Remember: The Critical Phase ends as soon as none of the criteria for the Critical Phase is fulfilled anymore AND the patient is free of fever. If the patient has died, it ends with the death of the patient. If the patient has died, do not report terminal values, i.e. those recorded after turning off life-support or heart rate "0" after death of the patient. Criteria of the Recovery Phase: *Improvement by at least one phase, i.e. Critical to Complicated or Complicated to Uncomplicated * Defervescence Remember: Uncomplicated asymptomatic patients enter recovery phase after 14 days of observation without disease progression No further progression or re-hospitalization If a text field can't be filled out, note 'ND' (for not determined).

Link

https://leoss.net

Palavras-chave

Versões (3)
  1. 02/07/2021 02/07/2021 - Sarah Riepenhausen
  2. 15/07/2021 15/07/2021 - Sarah Riepenhausen
  3. 16/07/2021 16/07/2021 - Sarah Riepenhausen
Titular dos direitos

LEOSS

Transferido a

16 de julho de 2021

DOI

10.21961/mdm:42476

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients

Inglês

Diabetes mellitus sub-cohort

23 Formulários  
Diabetes mellitus details
Descrição

Diabetes mellitus details

Alias
UMLS CUI-1
C0011849
UMLS CUI-2
C1522508
Diabetes mellitus type
Descrição

DM type

Tipo de dados

integer

Alias
UMLS CUI [1]
C1320657
Specification of type 3 diabetes mellitus
Descrição

E.g. steroid induced, MODY, pancreatic, NODAT.

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441731
UMLS CUI [1,3]
C1521902
Duration of Diabetes mellitus
Descrição

Indicate duration of Diabetes mellitus before diagnosis of SARS-CoV-2.

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0449238
Hemoglobin A1c (HbA1c ) in blood
Descrição

Hemoglobin A1c (HbA1c ) in blood

Alias
UMLS CUI-1
C0474680
Hemoglobin A1c (HbA1c ) in blood
Descrição

Indicate values determined closest to the first positive PCR.

Tipo de dados

integer

Alias
UMLS CUI [1]
C0474680
C-peptide in blood
Descrição

C-peptide in blood

Alias
UMLS CUI-1
C0006558
UMLS CUI-2
C0005768
C-peptide in blood at admission day
Descrição

Indicate values determined at admission day.

Tipo de dados

integer

Unidades de medida
  • pmol/l
Alias
UMLS CUI [1,1]
C0006558
UMLS CUI [1,2]
C0005768
UMLS CUI [1,3]
C1302393
C-peptide in blood at admission day +1, sober
Descrição

Indicate values determined in blood at next morning after admission, sober.

Tipo de dados

integer

Unidades de medida
  • pmol/l
Alias
UMLS CUI [1,1]
C2208720
UMLS CUI [1,2]
C0005768
UMLS CUI [1,3]
C0332170
UMLS CUI [1,4]
C0687676
UMLS CUI [1,5]
C1302393
Glucose in blood
Descrição

Glucose in blood

Alias
UMLS CUI-1
C0392201
Blood glucose level at admission day
Descrição

Indicate values determined at admission day.

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C1302393
UMLS CUI [1,2]
C0392201
Blood glucose level at admission day +1, fasting glucose
Descrição

Indicate values determined at next morning after admission, fasting glucose.

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0428568
UMLS CUI [1,2]
C0332170
UMLS CUI [1,3]
C0687676
UMLS CUI [1,4]
C1302393
C-peptide-to-Glucose Ratio (CGR) in blood
Descrição

C-peptide-to-Glucose Ratio (CGR) in blood

Alias
UMLS CUI-1
C0006558
UMLS CUI-2
C0017725
UMLS CUI-3
C0456603
UMLS CUI-4
C0005768
C-peptide-to-Glucose Ratio (CGR) at admission day
Descrição

Indicate values determined at admission day. C-peptide in (pmol/l); Glucose in (mg/dl).

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0006558
UMLS CUI [1,2]
C0017725
UMLS CUI [1,3]
C0456603
UMLS CUI [1,4]
C0005768
UMLS CUI [1,5]
C1302393
C-peptide-to-Glucose Ratio (CGR) at admission day +1, sober
Descrição

Indicate values determined at next morning after admission, sober. C-peptide in (pmol/l); Glucose in (mg/dl).

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0006558
UMLS CUI [1,2]
C0017725
UMLS CUI [1,3]
C0456603
UMLS CUI [1,4]
C0005768
UMLS CUI [1,5]
C0332170
UMLS CUI [1,6]
C0687676
UMLS CUI [1,7]
C1302393
UMLS CUI [1,8]
C0015663
Insulin level in blood
Descrição

Insulin level in blood

Alias
UMLS CUI-1
C0021641
UMLS CUI-2
C0005768
Insulin in blood at admission day
Descrição

Indicate values determined at admission day.

Tipo de dados

integer

Unidades de medida
  • mU/l
Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0005768
UMLS CUI [1,3]
C1302393
Insulin in blood at admission day +1, sober
Descrição

Indicate values determined at next morning after admission, sober.

Tipo de dados

integer

Unidades de medida
  • mU/l
Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0005768
UMLS CUI [1,3]
C0332170
UMLS CUI [1,4]
C0687676
UMLS CUI [1,5]
C1302393
UMLS CUI [1,6]
C0015663
Cortisol level in blood
Descrição

Cortisol level in blood

Alias
UMLS CUI-1
C0201968
UMLS CUI-2
C0005768
Cortisol level in blood at admission day
Descrição

Indicate values determined at admission day.

Tipo de dados

integer

Unidades de medida
  • µg/dl
Alias
UMLS CUI [1,1]
C0201968
UMLS CUI [1,2]
C0005768
UMLS CUI [1,3]
C1302393
Cortisol level in blood at admission day +1, sober
Descrição

Indicate values determined at next morning after admission, sober.

Tipo de dados

integer

Unidades de medida
  • µg/dl
Alias
UMLS CUI [1,1]
C0201968
UMLS CUI [1,2]
C0005768
UMLS CUI [1,3]
C0332170
UMLS CUI [1,4]
C0687676
UMLS CUI [1,5]
C1302393
UMLS CUI [1,6]
C0015663
Has insulin treatment been used before SARS-CoV-2 detection?
Descrição

Has insulin treatment been used before SARS-CoV-2 detection?

Alias
UMLS CUI-1
C0745343
UMLS CUI-2
C0332152
UMLS CUI-3
C1442488
Insulin treatment
Descrição

Indicate insulin treatment before diagnosis of SARS-CoV-2.

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0745343
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C1442488
Has the insulin scheme been changed at the time of SARS-CoV-2 detection (+/- 48 h)?
Descrição

Has the insulin scheme been changed at the time of SARS-CoV-2 detection (+/- 48 h)?

Alias
UMLS CUI-1
C0745343
UMLS CUI-2
C4319952
UMLS CUI-3
C1442488
Change of insulin scheme
Descrição

Change of insulin scheme before or after diagnosis of SARS-CoV-2 (+/- 48 h).

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0745343
UMLS CUI [1,2]
C4319952
UMLS CUI [1,3]
C1442488
Which oral antidiabetic treatment has been used before SARS-CoV-2 detection?
Descrição

Which oral antidiabetic treatment has been used before SARS-CoV-2 detection?

Alias
UMLS CUI-1
C0359086
UMLS CUI-2
C0332152
UMLS CUI-3
C1442488
Sulfonylureas
Descrição

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0038766
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C1442488
Metformin
Descrição

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C1442488
GLP-1 analogues
Descrição

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C3273809
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C1442488
DPP-4 blocker
Descrição

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1827106
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C1442488
SGLT-2 blocker
Descrição

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C3273807
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C1442488
Other treatment
Descrição

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0359086
UMLS CUI [1,3]
C0332152
UMLS CUI [1,4]
C1442488
Name of other oral antidiabetic treatment
Descrição

Indicate other oral antidiabetic treatment before Baseline

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0359086
UMLS CUI [1,3]
C1521902
UMLS CUI [1,4]
C0332152
UMLS CUI [1,5]
C1442488
None
Descrição

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0549184
UMLS CUI [1,2]
C0359086
UMLS CUI [1,3]
C0332152
UMLS CUI [1,4]
C1442488
Unknown
Descrição

Oral antidiabetic treatment before Baseline, unknown

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0359086
UMLS CUI [1,2]
C0439673
UMLS CUI [1,3]
C0332152
UMLS CUI [1,4]
C1442488
Is data entry for this section finished?
Descrição

Is data entry for this section finished?

Alias
UMLS CUI-1
C4684556
UMLS CUI-2
C1828479
UMLS CUI-3
C0205197
Is data entry for this section finished?
Descrição

Is data entry for this section finished?

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C4684556
UMLS CUI [1,2]
C1828479
UMLS CUI [1,3]
C0205197
Voltar ao início da página

Similar models

Diabetes mellitus sub-cohort

23 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Diabetes mellitus details
C0011849 (UMLS CUI-1)
C1522508 (UMLS CUI-2)
Item
Diabetes mellitus type
integer
C1320657 (UMLS CUI [1])
Diabetes type
Code List
Diabetes mellitus type
CL Item
Type 1 (1)
CL Item
Type 2 (2)
CL Item
Type 3 (e.g steroid induced, MODY, pancreatic, NODAT) (3)
CL Item
Unknown (4)
Specification of type 3 diabetes mellitus
Item
Specification of type 3 diabetes mellitus
text
C0011849 (UMLS CUI [1,1])
C0441731 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Item
Duration of Diabetes mellitus
integer
C0011849 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Duration of Diabetes
Code List
Duration of Diabetes mellitus
CL Item
<1 year (1)
CL Item
1-10 years (2)
CL Item
> 10 years (3)
CL Item
Unknown (4)
Item Group
Hemoglobin A1c (HbA1c ) in blood
C0474680 (UMLS CUI-1)
Item
Hemoglobin A1c (HbA1c ) in blood
integer
C0474680 (UMLS CUI [1])
Hemoglobin A1c (HbA1c ) in blood
Code List
Hemoglobin A1c (HbA1c ) in blood
CL Item
<6.4% (1)
CL Item
6.4% - 8% (2)
CL Item
8.1% - 10% (3)
CL Item
10.1 - 12 % (4)
CL Item
>12% (5)
CL Item
Unknown (6)
Item Group
C-peptide in blood
C0006558 (UMLS CUI-1)
C0005768 (UMLS CUI-2)
Item
C-peptide in blood at admission day
integer
C0006558 (UMLS CUI [1,1])
C0005768 (UMLS CUI [1,2])
C1302393 (UMLS CUI [1,3])
C-peptide admission
Code List
C-peptide in blood at admission day
CL Item
< 20 pmol/l (1)
CL Item
20-80 pmol/l (2)
CL Item
81-200 pmol/l (3)
CL Item
> 200 pmol/l (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item
C-peptide in blood at admission day +1, sober
integer
C2208720 (UMLS CUI [1,1])
C0005768 (UMLS CUI [1,2])
C0332170 (UMLS CUI [1,3])
C0687676 (UMLS CUI [1,4])
C1302393 (UMLS CUI [1,5])
C-peptide sober
Code List
C-peptide in blood at admission day +1, sober
CL Item
< 20 pmol/l (1)
CL Item
20-80 pmol/l (2)
CL Item
81-200 pmol/l (3)
CL Item
> 200 pmol/l (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item Group
Glucose in blood
C0392201 (UMLS CUI-1)
Item
Blood glucose level at admission day
integer
C1302393 (UMLS CUI [1,1])
C0392201 (UMLS CUI [1,2])
Blood glucose level: Admission day
Code List
Blood glucose level at admission day
CL Item
<100 mg/dl (1)
CL Item
100-126 mg/dl (2)
CL Item
127-200 mg/dl (3)
CL Item
>200 mg/dl (4)
CL Item
Unknown (5)
Item
Blood glucose level at admission day +1, fasting glucose
integer
C0428568 (UMLS CUI [1,1])
C0332170 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,3])
C1302393 (UMLS CUI [1,4])
Blood glucose level: Admission day +1 fasting glucose
Code List
Blood glucose level at admission day +1, fasting glucose
CL Item
<100 mg/dl (1)
CL Item
100-126 mg/dl (2)
CL Item
127-200 mg/dl (3)
CL Item
>200 mg/dl (4)
CL Item
Unknown (5)
Item Group
C-peptide-to-Glucose Ratio (CGR) in blood
C0006558 (UMLS CUI-1)
C0017725 (UMLS CUI-2)
C0456603 (UMLS CUI-3)
C0005768 (UMLS CUI-4)
Item
C-peptide-to-Glucose Ratio (CGR) at admission day
integer
C0006558 (UMLS CUI [1,1])
C0017725 (UMLS CUI [1,2])
C0456603 (UMLS CUI [1,3])
C0005768 (UMLS CUI [1,4])
C1302393 (UMLS CUI [1,5])
CGR: Admission day
Code List
C-peptide-to-Glucose Ratio (CGR) at admission day
CL Item
<2 (1)
CL Item
2 - 5 (2)
CL Item
>5 (3)
CL Item
Unknown (4)
Item
C-peptide-to-Glucose Ratio (CGR) at admission day +1, sober
integer
C0006558 (UMLS CUI [1,1])
C0017725 (UMLS CUI [1,2])
C0456603 (UMLS CUI [1,3])
C0005768 (UMLS CUI [1,4])
C0332170 (UMLS CUI [1,5])
C0687676 (UMLS CUI [1,6])
C1302393 (UMLS CUI [1,7])
C0015663 (UMLS CUI [1,8])
CGR: Admission day
Code List
C-peptide-to-Glucose Ratio (CGR) at admission day +1, sober
CL Item
<2 (1)
CL Item
2 - 5 (2)
CL Item
>5 (3)
CL Item
Unknown (4)
Item Group
Insulin level in blood
C0021641 (UMLS CUI-1)
C0005768 (UMLS CUI-2)
Item
Insulin in blood at admission day
integer
C0021641 (UMLS CUI [1,1])
C0005768 (UMLS CUI [1,2])
C1302393 (UMLS CUI [1,3])
Insulin Admission
Code List
Insulin in blood at admission day
CL Item
< 3 mU/l (1)
CL Item
3-20 mU/l (2)
CL Item
21-200 mU/l (3)
CL Item
> 200 mU/l  (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item
Insulin in blood at admission day +1, sober
integer
C0021641 (UMLS CUI [1,1])
C0005768 (UMLS CUI [1,2])
C0332170 (UMLS CUI [1,3])
C0687676 (UMLS CUI [1,4])
C1302393 (UMLS CUI [1,5])
C0015663 (UMLS CUI [1,6])
Insulin admission +1
Code List
Insulin in blood at admission day +1, sober
CL Item
< 3 mU/l (1)
CL Item
3-20 mU/l (2)
CL Item
21-200 mU/l (3)
CL Item
> 200 mU/l  (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item Group
Cortisol level in blood
C0201968 (UMLS CUI-1)
C0005768 (UMLS CUI-2)
Item
Cortisol level in blood at admission day
integer
C0201968 (UMLS CUI [1,1])
C0005768 (UMLS CUI [1,2])
C1302393 (UMLS CUI [1,3])
Cortisol admission
Code List
Cortisol level in blood at admission day
CL Item
< 2 µg/dl (1)
CL Item
2-10 µg/dl (2)
CL Item
11-20 µg/dl (3)
CL Item
> 20 µg/dl (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item
Cortisol level in blood at admission day +1, sober
integer
C0201968 (UMLS CUI [1,1])
C0005768 (UMLS CUI [1,2])
C0332170 (UMLS CUI [1,3])
C0687676 (UMLS CUI [1,4])
C1302393 (UMLS CUI [1,5])
C0015663 (UMLS CUI [1,6])
Cortisol admission +1
Code List
Cortisol level in blood at admission day +1, sober
CL Item
< 2 µg/dl (1)
CL Item
2-10 µg/dl (2)
CL Item
11-20 µg/dl (3)
CL Item
> 20 µg/dl (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item Group
Has insulin treatment been used before SARS-CoV-2 detection?
C0745343 (UMLS CUI-1)
C0332152 (UMLS CUI-2)
C1442488 (UMLS CUI-3)
Item
Insulin treatment
integer
C0745343 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
Has insulin treatment been used before SARS-CoV-2 detection?
Code List
Insulin treatment
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Has the insulin scheme been changed at the time of SARS-CoV-2 detection (+/- 48 h)?
C0745343 (UMLS CUI-1)
C4319952 (UMLS CUI-2)
C1442488 (UMLS CUI-3)
Item
Change of insulin scheme
integer
C0745343 (UMLS CUI [1,1])
C4319952 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
Has the insulin scheme been changed at the time of SARS-CoV-2 detection (+/- 48 h)?
Code List
Change of insulin scheme
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Which oral antidiabetic treatment has been used before SARS-CoV-2 detection?
C0359086 (UMLS CUI-1)
C0332152 (UMLS CUI-2)
C1442488 (UMLS CUI-3)
Sulfonylureas before Baseline
Item
Sulfonylureas
boolean
C0038766 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
Metformin before Baseline
Item
Metformin
boolean
C0025598 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
GLP-1 analogues before Baseline
Item
GLP-1 analogues
boolean
C3273809 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
DPP-4 blocker before Baseline
Item
DPP-4 blocker
boolean
C1827106 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
SGLT-2 blocker before Baseline
Item
SGLT-2 blocker
boolean
C3273807 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
Other oral antidiabetic treatment before Baseline
Item
Other treatment
boolean
C0205394 (UMLS CUI [1,1])
C0359086 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C1442488 (UMLS CUI [1,4])
Indicate other oral antidiabetic treatment before Baseline
Item
Name of other oral antidiabetic treatment
text
C0205394 (UMLS CUI [1,1])
C0359086 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,4])
C1442488 (UMLS CUI [1,5])
No oral antidiabetic treatment before Baseline
Item
None
boolean
C0549184 (UMLS CUI [1,1])
C0359086 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C1442488 (UMLS CUI [1,4])
Oral antidiabetic treatment before Baseline, unknown
Item
Unknown
boolean
C0359086 (UMLS CUI [1,1])
C0439673 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C1442488 (UMLS CUI [1,4])
Item Group
Is data entry for this section finished?
C4684556 (UMLS CUI-1)
C1828479 (UMLS CUI-2)
C0205197 (UMLS CUI-3)
Is data entry for this section finished?
Item
Is data entry for this section finished?
boolean
C4684556 (UMLS CUI [1,1])
C1828479 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial